A citation-based method for searching scientific literature

Anthony Pease, Clement Lo, Arul Earnest, Velislava Kiriakova, Danny Liew, Sophia Zoungas. Diabetes Technol Ther 2020
Times Cited: 5







List of co-cited articles
20 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets.
Molly L Tanenbaum, Sarah J Hanes, Kellee M Miller, Diana Naranjo, Rachel Bensen, Korey K Hood. Diabetes Care 2017
85
60

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
Sue A Brown, Boris P Kovatchev, Dan Raghinaru, John W Lum, Bruce A Buckingham, Yogish C Kudva, Lori M Laffel, Carol J Levy, Jordan E Pinsker, R Paul Wadwa,[...]. N Engl J Med 2019
109
40

Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials.
Gunjan Y Gandhi, Michelle Kovalaske, Yogish Kudva, Kristin Walsh, Mohamed B Elamin, Melody Beers, Cathy Coyle, Melissa Goalen, Mohammad Safwan Murad, Patricia J Erwin,[...]. J Diabetes Sci Technol 2011
61
40

Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Stéphane Roze, Jayne Smith-Palmer, William J Valentine, Mark Cook, Manisha Jethwa, Simona de Portu, John C Pickup. J Med Econ 2016
24
40

Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection.
Ulrik Pedersen-Bjergaard, Stig Pramming, Simon R Heller, Tara M Wallace, Ase K Rasmussen, Hanne V Jørgensen, David R Matthews, Philip Hougaard, Birger Thorsteinsson. Diabetes Metab Res Rev 2004
195
40

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Satish K Garg, Stuart A Weinzimer, William V Tamborlane, Bruce A Buckingham, Bruce W Bode, Timothy S Bailey, Ronald L Brazg, Jacob Ilany, Robert H Slover, Stacey M Anderson,[...]. Diabetes Technol Ther 2017
221
40

A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
Trang T Ly, Alan J M Brnabic, Andrew Eggleston, Athena Kolivos, Margaret E McBride, Rudolf Schrover, Timothy W Jones. Value Health 2014
25
40


Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France.
Stéphane Roze, Jayne Smith-Palmer, William Valentine, Vincent Payet, Simona de Portu, Natalie Papo, Michel Cucherat, Helene Hanaire. Diabetes Technol Ther 2016
18
40

Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
A Nicolucci, M C Rossi, D D'Ostilio, A Delbaere, S de Portu, S Roze. Nutr Metab Cardiovasc Dis 2018
3
66


Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
Johan Jendle, Johannes Pöhlmann, Simona de Portu, Jayne Smith-Palmer, Stéphane Roze. Diabetes Technol Ther 2019
11
40

Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark.
S Roze, S de Portu, J Smith-Palmer, A Delbaere, W Valentine, M Ridderstråle. Diabetes Res Clin Pract 2017
12
40

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
Richard M Bergenstal, Satish Garg, Stuart A Weinzimer, Bruce A Buckingham, Bruce W Bode, William V Tamborlane, Francine R Kaufman. JAMA 2016
250
40

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
E Cummins, P Royle, A Snaith, A Greene, L Robertson, L McIntyre, N Waugh. Health Technol Assess 2010
91
40


Insulin pump therapy: a meta-analysis.
Jill Weissberg-Benchell, Jeanne Antisdel-Lomaglio, Roopa Seshadri. Diabetes Care 2003
294
40


Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Rob Riemsma, Isaac Corro Ramos, Richard Birnie, Nasuh Büyükkaramikli, Nigel Armstrong, Steve Ryder, Steven Duffy, Gill Worthy, Maiwenn Al, Johan Severens,[...]. Health Technol Assess 2016
36
40

Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.
Kellee M Miller, Nicole C Foster, Roy W Beck, Richard M Bergenstal, Stephanie N DuBose, Linda A DiMeglio, David M Maahs, William V Tamborlane. Diabetes Care 2015
687
40

Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors.
R Westhovens, M Robles, A C Ximenes, S Nayiager, J Wollenhaupt, P Durez, J Gomez-Reino, W Grassi, B Haraoui, W Shergy,[...]. Ann Rheum Dis 2009
202
20

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.
Jerry P Palmer, G Alexander Fleming, Carla J Greenbaum, Kevan C Herold, Lisa D Jansa, Hubert Kolb, John M Lachin, Kenneth S Polonsky, Paolo Pozzilli, Jay S Skyler,[...]. Diabetes 2004
309
20

Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients.
Bart Keymeulen, Sophie Candon, Samira Fafi-Kremer, Anette Ziegler, Marianne Leruez-Ville, Chantal Mathieu, Evy Vandemeulebroucke, Markus Walter, Laurent Crenier, Eric Thervet,[...]. Blood 2010
51
20

Changing the landscape for type 1 diabetes: the first step to prevention.
Colin M Dayan, Maria Korah, Danijela Tatovic, Brian N Bundy, Kevan C Herold. Lancet 2019
14
20

Porcine CTLA4-Ig prolong islet xenografts in rats by downregulating the direct pathway of T-cell activation.
Chao Zhai, Liang Yu, Haitao Zhu, Min Tian, Zhang Xiaogang, Wang Bo. Xenotransplantation 2011
12
20

Immunotherapy of type 1 diabetes: where are we and where should we be going?
Xunrong Luo, Kevan C Herold, Stephen D Miller. Immunity 2010
90
20



Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.
Jay S Skyler, George L Bakris, Ezio Bonifacio, Tamara Darsow, Robert H Eckel, Leif Groop, Per-Henrik Groop, Yehuda Handelsman, Richard A Insel, Chantal Mathieu,[...]. Diabetes 2017
146
20

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.
C P Larsen, E T Elwood, D Z Alexander, S C Ritchie, R Hendrix, C Tucker-Burden, H R Cho, A Aruffo, D Hollenbaugh, P S Linsley,[...]. Nature 1996
20

Long-term safety of subcutaneous abatacept in rheumatoid arthritis: integrated analysis of clinical trial data representing more than four years of treatment.
Rieke Alten, Jeffrey Kaine, Edward Keystone, Peter Nash, Ingrid Delaet, Mark C Genovese. Arthritis Rheumatol 2014
42
20

A new member of the immunoglobulin superfamily--CTLA-4.
J F Brunet, F Denizot, M F Luciani, M Roux-Dosseto, M Suzan, M G Mattei, P Golstein. Nature 1987
663
20

Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus.
R Assan, G Feutren, M Debray-Sachs, M C Quiniou-Debrie, C Laborie, G Thomas, L Chatenoud, J F Bach. Lancet 1985
112
20

Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion.
Larry W Moreland, Rieke Alten, Filip Van den Bosch, Thierry Appelboom, Marc Leon, Paul Emery, Stanley Cohen, Michael Luggen, William Shergy, Isaac Nuamah,[...]. Arthritis Rheum 2002
242
20


Pharmacokinetics and pharmacodynamics of CTLA4lg (BMS-188667), a novel immunosuppressive agent, in monkeys following multiple doses.
N R Srinivas, R S Weiner, G Warner, W C Shyu, T Davidson, C G Fadrowski, L K Tay, J S Lee, D S Greene, R H Barbhaiya. J Pharm Sci 1996
12
20


Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes.
Kimber M Simmons, Peter A Gottlieb, Aaron W Michels. Curr Diab Rep 2016
12
20

Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study.
Francesco Ursini, Emilio Russo, Marta Letizia Hribal, Daniele Mauro, Francesca Savarino, Caterina Bruno, Cesare Tripolino, Mariangela Rubino, Saverio Naty, Rosa Daniela Grembiale. Medicine (Baltimore) 2015
35
20

Blockade of both B7-H4 and CTLA-4 co-signaling pathways enhances mouse islet allograft survival.
Xiaojie Wang, Jianqiang Hao, Daniel L Metzger, Alice Mui, I-Fang Lee, Noushin Akhoundsadegh, C Lieping Chen, Dawei Ou, Ziliang Ao, C Bruce Verchere,[...]. Islets 2012
3
33

Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment.
Tihamer Orban, Brian Bundy, Dorothy J Becker, Linda A Dimeglio, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Carla J Greenbaum, Jennifer B Marks, Roshanak Monzavi,[...]. Diabetes Care 2014
98
20

Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data.
Carla J Greenbaum, Craig A Beam, David Boulware, Stephen E Gitelman, Peter A Gottlieb, Kevan C Herold, John M Lachin, Paula McGee, Jerry P Palmer, Mark D Pescovitz,[...]. Diabetes 2012
175
20

Immunogenicity, safety, and efficacy of abatacept administered subcutaneously with or without background methotrexate in patients with rheumatoid arthritis: results from a phase III, international, multicenter, parallel-arm, open-label study.
Peter Nash, Sauithree Nayiager, Mark C Genovese, Alan J Kivitz, Kurt Oelke, Charles Ludivico, William Palmer, Cristian Rodriguez, Ingrid Delaet, Ayanbola Elegbe,[...]. Arthritis Care Res (Hoboken) 2013
52
20

Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes.
Ronnie Aronson, Peter A Gottlieb, Jens S Christiansen, Thomas W Donner, Emanuele Bosi, Bruce W Bode, Paolo Pozzilli. Diabetes Care 2014
62
20

Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study).
Jeffrey Kaine, Geoffrey Gladstein, Ingrid Strusberg, Manuel Robles, Ingrid Louw, Sheila Gujrathi, Ramesh Pappu, Ingrid Delaet, Miranda Pans, Charles Ludivico. Ann Rheum Dis 2012
48
20

Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis.
Philip J Mease, Alice B Gottlieb, Désirée van der Heijde, Oliver FitzGerald, Alyssa Johnsen, Marleen Nys, Subhashis Banerjee, Dafna D Gladman. Ann Rheum Dis 2017
87
20

Type 1 diabetes.
Mark A Atkinson, George S Eisenbarth, Aaron W Michels. Lancet 2014
860
20

New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes.
Miriam Cabello-Olmo, Miriam Araña, Ilian Radichev, Paul Smith, Eduardo Huarte, Miguel Barajas. Int J Mol Sci 2019
3
33

The clinical impact of islet transplantation.
P Fiorina, A M J Shapiro, C Ricordi, A Secchi. Am J Transplant 2008
141
20

Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Protégé trial.
William Hagopian, Robert J Ferry, Nicole Sherry, David Carlin, Ezio Bonvini, Syd Johnson, Kathryn E Stein, Scott Koenig, Anastasia G Daifotis, Kevan C Herold,[...]. Diabetes 2013
101
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.